Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.

Abstract

Variant angina is a form of angina pectoris that shows transient ST-segment elevation on electrocardiogram during an attack of chest pain. Ischemic episodes of variant angina show circadian variation and often occur at rest from midnight to early morning. Ischemic episodes also occur during mild exercise in the early morning. However, they are not usually induced by strenuous exercise in the afternoon. Other important clinical features of variant angina include the high frequency of asymptomatic ischemic episodes and the syncope that sometimes occur during the ischemic episodes. Syncope is due to severe arrhythmias, including ventricular tachycardia, ventricular fibrillation, and high-degree atrioventricular block. Coronary artery spasm is the mechanism of ischemic episodes in variant angina. The incidence of coronary artery spasm shows a racial difference and is higher in Japanese than in Caucasians. Coronary arteriograms are normal or near-normal in most Japanese patients with variant angina. Deficient basal release of nitric oxide (NO) due to endothelial dysfunction, and enhanced vascular smooth muscle contractility with the involvement of the Rho/Rho-kinase pathway are reported to play important roles in the pathogenesis of coronary artery spasm. Other precipitating factors of coronary artery spasm include imbalance in autonomic nervous activity, increased oxidative stress, chronic low-grade inflammation, magnesium deficiency, and genetic susceptibility. The genetic risk factors associated with coronary artery spasm include gene polymorphisms of endothelial NO synthase (NOS), paraoxonase, and other genes. Calcium channel blockers are extremely effective in preventing coronary spasm. The long-acting nitrate, nicorandil, and Rho-kinase inhibitor are also useful for inhibiting coronary artery spasm. Because variant angina can lead to acute myocardial infarction, fatal arrhythmias, and sudden death, early treatment is important. The prognosis of patients with variant angina is favorable, if early complications can be overcome. However, because coronary artery spasm cannot be suppressed in some patients, even with multiple medications, medications to suppress intractable coronary artery spasm must be developed.

• Authors: Yoshiki Kusama, Eitaro Kodani, Akihiro Nakagomi, Toshiaki Otsuka, Hirotsugu Atarashi, Hiroshi Kishida, Kyoichi Mizuno
• Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi (J Nippon Med Sch) Vol. 78 Issue 1 Pg. 4-12 ( 2011) ISSN: 1347-3409 [Electronic] Japan
• PMID: 21389642 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Arrhythmia Agents
• Calcium Channel Blockers
• Nitrates
• Nicorandil

Topics

• Angina Pectoris, Variant (drug therapy, pathology, physiopathology)
• Anti-Arrhythmia Agents (therapeutic use)
• Calcium Channel Blockers (therapeutic use)
• Circadian Rhythm (physiology)
• Coronary Vasospasm (drug therapy, pathology, physiopathology)
• Drug Therapy, Combination
• Electrocardiography (methods)
• Humans
• Nicorandil (therapeutic use)
• Nitrates (therapeutic use)